| Literature DB >> 30419762 |
Heide Brandhorst1,2,3, Paul R Johnson1,2,4, Johanna Mönch5, Manfred Kurfürst5, Olle Korsgren3, Daniel Brandhorst1,2,3.
Abstract
Although human islet transplantation has been established as valid and safe treatment for patients with type 1 diabetes, the utilization rates of human pancreases for clinical islet transplantation are still limited and substantially determined by the quality and composition of collagenase blends. While function and integrity of collagenase has been extensively investigated, information is still lacking about the most suitable supplementary neutral proteases. The present study compared islet isolation outcome after pancreas digestion by means of collagenase used alone or supplemented with either neutral protease (NP), clostripain (CP), or both proteases. Decent amounts of islet equivalents (IEQ) were isolated using collagenase alone (3090 ± 550 IEQ/g), or in combination with NP (2340 ± 450 IEQ/g) or CP (2740 ± 280 IEQ/g). Nevertheless, the proportion of undigested tissue was higher after using collagenase alone (21.1 ± 1.1%, P < 0.05) compared with addition of NP (13.3 ± 2.2%) or CP plus NP (13.7 ± 2.6%). Likewise, the percentage of embedded islets was highest using collagenase only (13 ± 2%) and lowest adding NP plus CP (4 ± 1%, P < 0.01). The latter combination resulted in lowest post-culture overall survival (42.7 ± 3.9%), while highest survival was observed after supplementation with CP (74.5 ± 4.8%, P < 0.01). An insulin response toward glucose challenge was present in all experimental groups, but the stimulation index was significantly decreased using collagenase plus NP (2.0 ± 0.12) compared with supplementation with CP (3.16 ± 0.4, P < 0.001). This study demonstrates for the first time that it is possible to isolate significant numbers of human islets combining collagenase only with CP. The supplementation with CP is an effective means to substantially reduce NP activity, which significantly decreases survival and viability after culture. This will facilitate the manufacturing of enzyme blends with less harmful characteristics.Entities:
Keywords: clostripain; collagenase; human islet isolation; human islet transplantation; neutral protease
Year: 2018 PMID: 30419762 PMCID: PMC6362525 DOI: 10.1177/0963689718811614
Source DB: PubMed Journal: Cell Transplant ISSN: 0963-6897 Impact factor: 4.064
Enzyme Blending.
| Supplementary protease |
| Collagenase (PZ-U/g) | NP (DMC-U/g) | CP (BAEE-U/g) |
|---|---|---|---|---|
| w/o | 6 | 22.3 ± 1.0 | 0.14 ± 0.01 | 0.33 ± 0.05 |
| NP | 9 | 22.3 ± 0.9 | 1.33 ± 0.07 | 0.27 ± 0.01 |
| CP | 9 | 22.7 ± 0.7 | 0.14 ± 0.00 | 2.28 ± 0.08 |
| NP + CP | 6 | 22.7 ± 1.3 | 1.35 ± 0.10 | 2.22 ± 0.17 |
w/o: without protease supplementation; NP: neutral protease activity (DMC-U, dimethyl-casein-units); CP: clostripain activity (BAEE-U, benzoyl-l-arginine-ethyl-ester-units); PZ-U: phenylazobenzyloxycarbonyl-l-prolyl-l-leucylglycyl-prolyl-d-arginine-units.
Donor Characteristics.
| Supplementary protease |
| Gender (male/female) | Age (years) | BMI (kg/m2) | CIT (hours) | Serum Amylase (U/L) | Vasopressors (yes/no) | Pancreas (g) |
|---|---|---|---|---|---|---|---|---|
| w/o | 6 | 3/3 | 60 ± 5 | 23 ± 1 | 11 ± 2 | 43 ± 25 | 6/0 | 74 ± 5 |
| NP | 9 | 3/6 | 58 ± 3 | 24 ± 1 | 11 ± 2 | 37 ± 3 | 8/1 | 86 ± 6 |
| CP | 9 | 4/5 | 57 ± 4 | 26 ± 1 | 11 ± 1 | 36 ± 2 | 8/1 | 76 ± 6 |
| NP + CP | 6 | 2/4 | 58 ± 3 | 26 ± 3 | 11 ± 2 | 42 ± 12 | 5/1 | 83 ± 9 |
w/o: without protease supplementation; NP: neutral protease; CP: clostripain; BMI: body mass index; CIT: cold ischemia time.
Digestion Variables.
| Supplementary protease |
| Recirculation time (min) | Packed tissue (µL/g) | Undigested tissue (%) |
|---|---|---|---|---|
| w/o | 6 | 26 ± 2 | 397 ± 49 | 21.1 ± 1.1 |
| NP | 9 | 21 ± 1a,b | 539 ± 57 | 13.3 ± 2.2a |
| CP | 9 | 25 ± 1 | 528 ± 50 | 16.6 ± 2.2 |
| NP + CP | 6 | 22 ± 1c | 507 ± 68 | 13.7 ± 2.6a |
w/o: without protease supplementation; NP: neutral protease; CP: clostripain.
a P < 0.05 vs. w/o.; bP < 0.01 vs. CP; cP < 0.05 vs. CP
Islet Isolation Outcome.
| Supplementary protease |
| Total islet yield (IEQ/pancreas) | Islet yield (IEQ/g) | Fragmentation score (0 – 3) | Embedded islets (%) | Islet purity (%) | Viability (%) |
|---|---|---|---|---|---|---|---|
| w/o | 6 | 222250 ± 67510 | 3090 ± 550 | 0.8 ± 0.3 | 13 ± 2 | 59 ± 5 | 78.9 ± 1.7 |
| NP | 9 | 211790 ± 58750 | 2340 ± 450 | 1.2 ± 0.3 | 9 ± 2 | 49 ± 6b | 75.7 ± 2.5 |
| CP | 9 | 209430 ± 29030 | 2740 ± 280 | 0.8 ± 0.2 | 11 ± 4 | 64 ± 6 | 81.4 ± 2.3 |
| NP + CP | 6 | 283230 ± 56660 | 3430 ± 630 | 1.3 ± 0.4 | 4 ± 1a | 63 ±10 | 73.1 ± 4.3 |
w/o: without protease supplementation; NP: neutral protease; CP: clostripain; IEQ: islet equivalent.
a P < 0.01 vs. w/o; bP < 0.05 vs. CP.
Islet Culture Outcome.
| Supplementary protease |
| Islet recovery (%) | Islet purity (%) | Viability (%) | Overall survival (%) | Formazan (OD/100 IEQ) | Stimulation index (20/2 mM) | Intracellular insulin (µU/islet) |
|---|---|---|---|---|---|---|---|---|
| w/o | 6 | 70.2 ± 6.1a | 52 ± 5† | 75.3 ± 1.9† | 52.9 ± 5.1a | 8.5 ± 0.8 | 2.28 ± 0.15a | 609 ± 104 |
| NP | 9 | 67.6 ± 6.1b | 46 ± 6 | 72.8 ± 2.6a,‡ | 48.3 ± 6.4b | 8.7 ± 1.3 | 2.00 ± 0.12 | 712 ± 95 |
| CP | 9 | 94.4 ± 5.2 | 62 ± 6 | 81.6 ± 2.8 | 74.5 ± 4.8 | 10.4 ± 1.3 | 3.16 ± 0.40d | 685 ± 82 |
| NP + CP | 6 | 66.5 ± 4.6b | 61 ± 10 | 66.3 ± 4.0b,† | 42.7 ± 3.9b | 9.2 ± 1.4 | 2.95 ± 0.59c | 421 ± 99a,c |
w/o: without protease supplementation; NP: neutral protease; CP: clostripain; OD: optical density.
a P < 0.05, bP < 0.01 vs. CP; cP < 0.05, dP < 0.001 vs. NP; †P < 0.05, ‡P < 0.01 vs. post-isolation (Table 4).
Fig 1.Glucose-stimulated insulin secretion of human islets isolated with collagenase used without supplementary proteases (w/o, n = 6) or supplemented with NP (n = 9), CP (n = 9) or a combination of NP plus CP (n = 6). After culture for 3–4 days at 37°C, islets were sequentially incubated for 45 min at 2 (white bars), 20 (grey bars) and again 2 mmol/L of glucose. Insulin release is normalized to intracellular insulin content. Dunn’s test following Friedman test revealed *P < 0.05, **P < 0.01, ***P < 0.001 for insulin secretion at 20 vs. 2 mmol/L glucose. Dunn’s test following Kruskal–Wallis test revealed P < 0.05 for intracellular insulin content comparing NP vs. NP plus CP.